190 related articles for article (PubMed ID: 25827817)
1. Clinical follow-up does not improve survival after resection of stage I-III colorectal cancer: A cohort study.
Jones RP; McWhirter D; Fretwell VL; McAvoy A; Hardman JG
Int J Surg; 2015 May; 17():67-71. PubMed ID: 25827817
[TBL] [Abstract][Full Text] [Related]
2. Association Between Intensity of Posttreatment Surveillance Testing and Detection of Recurrence in Patients With Colorectal Cancer.
Snyder RA; Hu CY; Cuddy A; Francescatti AB; Schumacher JR; Van Loon K; You YN; Kozower BD; Greenberg CC; Schrag D; Venook A; McKellar D; Winchester DP; Chang GJ;
JAMA; 2018 May; 319(20):2104-2115. PubMed ID: 29800181
[TBL] [Abstract][Full Text] [Related]
3. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial.
Primrose JN; Perera R; Gray A; Rose P; Fuller A; Corkhill A; George S; Mant D;
JAMA; 2014 Jan; 311(3):263-70. PubMed ID: 24430319
[TBL] [Abstract][Full Text] [Related]
4. Minimally invasive surgery for colorectal cancer. Initial follow-up.
Hoffman GC; Baker JW; Doxey JB; Hubbard GW; Ruffin WK; Wishner JA
Ann Surg; 1996 Jun; 223(6):790-6; discussion 796-8. PubMed ID: 8645052
[TBL] [Abstract][Full Text] [Related]
5. Risk-stratified intensive follow up for treated colorectal cancer - realistic and cost saving?
Macafee DA; Whynes DK; Scholefield JH
Colorectal Dis; 2008 Mar; 10(3):222-30. PubMed ID: 17645572
[TBL] [Abstract][Full Text] [Related]
6. Is early surveillance with CT scan necessary in patients with stage II/III colorectal cancer: a retrospective study.
Liu GC; Tang JH; Wen SJ; Cao HX; An X; Cai PQ; Kong LH; Lin JZ; Li LR; Pan ZZ; Ding PR
J Surg Oncol; 2013 Dec; 108(8):568-71. PubMed ID: 24105780
[TBL] [Abstract][Full Text] [Related]
7. Intensive risk-adjusted follow-up with the CEA, TPA, CA19.9, and CA72.4 tumor marker panel and abdominal ultrasonography to diagnose operable colorectal cancer recurrences: effect on survival.
Nicolini A; Ferrari P; Duffy MJ; Antonelli A; Rossi G; Metelli MR; Fulceri F; Anselmi L; Conte M; Berti P; Miccoli P
Arch Surg; 2010 Dec; 145(12):1177-83. PubMed ID: 21173292
[TBL] [Abstract][Full Text] [Related]
8. Thoracic recurrence in patients with curatively-resected colorectal cancer: incidence, risk factors, and value of chest CT as a postoperative surveillance tool.
Lee JH; Park CM; Joo I; Suh YJ; Hwang EJ; Kim H; Goo JM
Eur Radiol; 2019 Aug; 29(8):4303-4314. PubMed ID: 30350166
[TBL] [Abstract][Full Text] [Related]
9. Routine follow-up by magnetic resonance imaging does not improve detection of resectable local recurrences from colorectal cancer.
Titu LV; Nicholson AA; Hartley JE; Breen DJ; Monson JR
Ann Surg; 2006 Mar; 243(3):348-52. PubMed ID: 16495699
[TBL] [Abstract][Full Text] [Related]
10. The value of routine serum carcino-embryonic antigen measurement and computed tomography in the surveillance of patients after adjuvant chemotherapy for colorectal cancer.
Chau I; Allen MJ; Cunningham D; Norman AR; Brown G; Ford HE; Tebbutt N; Tait D; Hill M; Ross PJ; Oates J
J Clin Oncol; 2004 Apr; 22(8):1420-9. PubMed ID: 15007086
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer.
Vallam KC; Guruchannabasavaiah B; Agrawal A; Rangarajan V; Ostwal V; Engineer R; Saklani A
Colorectal Dis; 2017 Oct; 19(10):907-911. PubMed ID: 28444968
[TBL] [Abstract][Full Text] [Related]
12. Impact of low skeletal muscle mass and density on short and long-term outcome after resection of stage I-III colorectal cancer.
van Vugt JLA; Coebergh van den Braak RRJ; Lalmahomed ZS; Vrijland WW; Dekker JWT; Zimmerman DDE; Vles WJ; Coene PLO; IJzermans JNM
Eur J Surg Oncol; 2018 Sep; 44(9):1354-1360. PubMed ID: 29914788
[TBL] [Abstract][Full Text] [Related]
13. Utility of postoperative CEA for surveillance of recurrence after resection of primary colorectal cancer.
Bhatti I; Patel M; Dennison AR; Thomas MW; Garcea G
Int J Surg; 2015 Apr; 16(Pt A):123-128. PubMed ID: 25771102
[TBL] [Abstract][Full Text] [Related]
14. Strict follow-up programme including CT and ¹⁸F-FDG-PET after curative surgery for colorectal cancer.
Sørensen NF; Jensen AB; Wille-Jørgensen P; Friberg L; Rørdam L; Ingeman L; Hennild V
Colorectal Dis; 2010 Oct; 12(10 Online):e224-8. PubMed ID: 20002699
[TBL] [Abstract][Full Text] [Related]
15. Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases.
Araujo RL; Gönen M; Allen P; DeMatteo R; Kingham P; Jarnagin W; D'Angelica M; Fong Y
Ann Surg Oncol; 2015 Sep; 22(9):3087-93. PubMed ID: 25582745
[TBL] [Abstract][Full Text] [Related]
16. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
Veingerl B
Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer.
Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M
J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427
[TBL] [Abstract][Full Text] [Related]
18. The role of periodic serum CA19-9 test in surveillance after colorectal cancer surgery.
Okamura R; Hasegawa S; Hida K; Hoshino N; Kawada K; Sugihara K; Sakai Y;
Int J Clin Oncol; 2017 Feb; 22(1):96-101. PubMed ID: 27503134
[TBL] [Abstract][Full Text] [Related]
19. Preoperative neutrophil to lymphocyte ratio >5 is a prognostic factor for recurrent colorectal cancer.
Mallappa S; Sinha A; Gupta S; Chadwick SJ
Colorectal Dis; 2013 Mar; 15(3):323-8. PubMed ID: 22958479
[TBL] [Abstract][Full Text] [Related]
20. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study.
Pietra N; Sarli L; Costi R; Ouchemi C; Grattarola M; Peracchia A
Dis Colon Rectum; 1998 Sep; 41(9):1127-33. PubMed ID: 9749496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
